ARCHIVES

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Rep. Bruce Vento (D-MN) Has Cancer, Will Not Seek Re-Election.

February 4, 2000

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

March 5, 1999

Reauthorization Battle Warms Up; Administration, But Not Wyngaarden, May OK Cancer Act Renewal

March 18, 1988

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

March 12, 1999

Toxic Substance Act Would Affect Cancer Program

March 21, 1975

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987